UNSPSC 51112611: Ranimustine

This classification denotes a nitrosourea compound with the molecular formula C10H18ClN3O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RYH2T97J77, chemically known as glucopyranoside, methyl-6-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-6-deoxy-, alpha-d- but more generally known as ranimustine, which bears US NIH Compound Identifier 71741. European Medicines Agency schedules Ranimustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10256MIG.

UNSPSC 51112611 Ranimustine is a Commodity code for procurement of this nitrogen mustard chemotherapy agent, used in state and local healthcare settings. State and local governments procure ranimustine primarily through health departments, correctional healthcare systems, state hospital networks, and county medical facilities that operate oncology or hematology treatment programs. The drug is typically acquired as part of broader pharmaceutical supply contracts or stand-alone oncology medication RFQs and ITBs issued by healthcare procurement offices. Quantities and formulations vary by facility size and patient population served, with larger state hospital systems and academic medical centers generally representing the largest volume buyers in this commodity space.

The source provided contains no recent state and local contract opportunities posted under this code. Without posted solicitations, geographic concentration cannot be characterized, and representative recent opportunities cannot be named. Procurement activity for this specific pharmaceutical commodity at the state and local level remains opaque based on available data.